Novo Nordisk Secures Global Licensing Agreement with Ascendis Pharma for TransCon Technology
Denmark-based healthcare giant Novo Nordisk (NYSE: NVO; CPH: NOVO-B) has entered into a licensing agreement...
Mirxes Holding Company Updates IPO Prospectus with 2024 Financials
Mirxes Holding Company Ltd, a Singapore-based RNA technology company specializing in blood-based miRNA test kit...
Insilico Medicine Secures Revolving Loan Facility with HSBC to Boost Drug Discovery Pipeline
China-based artificial intelligence (AI) drug developer Insilico Medicine has announced the establishment of a Revolving...
Shanghai HeartCare Medical Technology Receives NMPA Approval for Embolization Stent
China’s National Medical Products Administration (NMPA) has granted marketing approval to Shanghai HeartCare Medical Technology...
Boehringer Ingelheim Partners with Broad Institute for Mental Health Treatments
Germany-based pharmaceutical major Boehringer Ingelheim has entered into a collaboration agreement with the Stanley Center...
HuidaGene Receives FDA Clinical Clearance for HG202 in Neovascular AMD Treatment
China-based HuidaGene (Shanghai) Biotechnology Co., Ltd has announced receiving clinical clearance from the US Food...
NMPA Grants Marketing License to Abonisi Medical Technology’s Knee Joint Prosthesis System
China’s National Medical Products Administration (NMPA) has issued a marketing license to Abonisi Medical Technology...
Isap Biotech Secures FDA IND Approval for iSAP-0909 for Bladder Cancer Imaging
Beijing-based biotech firm Isap Biotech has announced that it has received Investigational New Drug (IND)...
China Grand Pharmaceutical Completes Phase III Clinical Study for Post-Cataract Surgery Treatment
China Grand Pharmaceutical and Healthcare Holdings Ltd (HKG: 0512; CGP) has announced the successful completion...
111 Inc. Appoints Yang “Luke” Chen to Board of Directors Following Resignation of Dr. Lian Yong Chen
China-based online pharmacy 111 Inc. (NASDAQ: YI) has announced the appointment of its Senior Finance...
Shanghai RMX Biopharma and PharmaEngine Ink Distribution Deal for Liporaxel in Taiwan
Chinese firms Shanghai RMX Biopharma Co. Ltd., a subsidiary of Haihe Biopharma Co., Ltd., and...
China’s National Allied Procurement Office Launches 10th VBP Tender Round Information Filing
The National Allied Procurement Office has released a notification initiating the information filing process for...
NMPA Releases 84th Batch of Reference Drugs for GQCE and First Batch Stripped of Status
The National Medical Products Administration (NMPA) has released the 84th batch of reference drugs for...
J&J MedTech Completes Pilot Enrollment for OMNY-AF Study on Atrial Fibrillation Treatment
US major Johnson & Johnson (J&J, NYSE: JNJ) MedTech has announced the completion of pilot...
Innorna Co., Ltd Receives FDA Rare Pediatric Disease Designation for mRNA Drug IN015
Shenzhen-based Innorna Co., Ltd has announced that it has received Rare Pediatric Disease Designation (RPDD)...
Teva Pharmaceutical Reports Positive Phase III Results for TEV-‘749 in Schizophrenia Trial
Israel-based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has released new positive data on social functioning...
Neurodawn Pharmaceutical Secures Hundreds of Millions in Series C Financing
Nanjing-based central nervous system (CNS) drug developer, Neurodawn Pharmaceutical Co., Ltd, has announced the successful...
Suzhou Basecare Medical’s BKA210 Receives Marketing Approval in Jiangsu Province
China-based in vitro fertilization (IVF) specialist Suzhou Basecare Medical Co., Ltd (HKG: 2170) has announced...
Reprogenix Secures Over RMB100 Million in Series A Financing Led by China Venture Capital
Hangzhou-based stem cell specialist Reprogenix has announced the successful completion of a Series A financing...
Novo Nordisk’s Semaglutide Meets Primary Endpoints in ESSENCE Phase III Study for MASH
Denmark-based pharmaceutical company Novo Nordisk (NYSE: NVO; CPH: Novo-B) has announced that part 1 of...